Zhao Yin Guo Ji·2026-02-06 01:44Industry Insights - The Chinese medical examination industry is experiencing rapid growth, driven by an aging population and increasing health awareness, with a projected CAGR of 9.2% from 2020 to 2024 and an accelerated growth of 18.3% from 2024 to 2030 [6] - The penetration rate of medical examinations in China is approximately 40%, significantly lower than the 70% in developed countries, indicating substantial room for growth [6] - The market is characterized by a "public-led, private-catching-up" dynamic, with public hospitals holding a 69% market share and private institutions increasing their share to 24% [6] - Leading private examination institutions, such as Meinian Health and Aikang Guobin, are focusing on high-end services, which has resulted in an increase in average selling price (ASP) and profit margins [6] Company Insights - Google (GOOG US) reported a 4Q25 revenue growth of 18% to $113.8 billion, driven by strong performance in search and cloud services, with operating profit increasing by 16% to $35.9 billion [7] - The management has guided for capital expenditures of $175-185 billion for FY26E, significantly above consensus estimates, indicating a strong commitment to AI investments [7] - Zhongji Xuchuang (300308 CH) remains a solid investment, with a focus on pluggable optical modules expected to dominate the market during 2026-27, despite recent stock volatility [8] - Jizhi Jia (2590 HK) announced a 31.7% year-on-year increase in new orders for 2025, totaling 4.1 billion RMB, attributed to stable growth in mature markets and breakthroughs in specific sectors [9]